BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-szalmas P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. Journal of Hepatology 2013;59:457-66. [DOI: 10.1016/j.jhep.2013.04.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Tornai T, Palyu E, Vitalis Z, Tornai I, Tornai D, Antal-Szalmas P, Norman GL, Shums Z, Veres G, Dezsofi A, Par G, Par A, Orosz P, Szalay F, Lakatos PL, Papp M. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World J Gastroenterol 2017; 23(29): 5412-5421 [PMID: 28839442 DOI: 10.3748/wjg.v23.i29.5412] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
2 Sowa M, Kolenda R, Baumgart DC, Pratschke J, Papp M, Tornai T, Suchanski J, Bogdanos DP, Mytilinaiou MG, Hammermann J, Laass MW, Conrad K, Schramm C, Franke A, Roggenbuck D, Schierack P. Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype. Front Immunol 2018;9:1959. [PMID: 30233574 DOI: 10.3389/fimmu.2018.01959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tornai T, Tornai D, Sipeki N, Tornai I, Alsulaimani R, Fechner K, Roggenbuck D, Norman GL, Veres G, Par G, Par A, Szalay F, Lakatos PL, Antal-Szalmas P, Papp M. Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. Sci Rep 2018;8:399. [PMID: 29321484 DOI: 10.1038/s41598-017-18622-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
4 Tuchendler E, Tuchendler PK, Madej G. Immunodeficiency caused by cirrhosis. Clin Exp Hepatol 2018;4:158-64. [PMID: 30324140 DOI: 10.5114/ceh.2018.78119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Albillos A, Lario M, Álvarez-mon M. Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. Journal of Hepatology 2014;61:1385-96. [DOI: 10.1016/j.jhep.2014.08.010] [Cited by in Crossref: 470] [Cited by in F6Publishing: 429] [Article Influence: 58.8] [Reference Citation Analysis]
6 Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M. Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int. 2016; Epub ahead of print. [PMID: 27031405 DOI: 10.1111/liv.13133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
7 Lv LX, Fang DQ, Shi D, Chen DY, Yan R, Zhu YX, Chen YF, Shao L, Guo FF, Wu WR, Li A, Shi HY, Jiang XW, Jiang HY, Xiao YH, Zheng SS, Li LJ. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol. 2016;18:2272-2286. [PMID: 27243236 DOI: 10.1111/1462-2920.13401] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 19.2] [Reference Citation Analysis]
8 Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641-656. [PMID: 29806487 DOI: 10.1080/17474124.2018.1481747] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
9 Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1]. J Crohns Colitis 2015;9:659-68. [PMID: 25968583 DOI: 10.1093/ecco-jcc/jjv087] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
10 Dinya T, Tornai T, Vitalis Z, Tornai I, Balogh B, Tornai D, Antal-Szalmas P, Sumegi A, Andrikovics H, Bors A, Tordai A, Papp M. Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis. Liver Int 2018;38:1242-52. [PMID: 29235260 DOI: 10.1111/liv.13664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20(10): 2564-2577 [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 92] [Article Influence: 13.0] [Reference Citation Analysis]
12 Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Antal Szalmas P, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn’s disease. World J Gastroenterol 2015; 21(22): 6952-6964 [PMID: 26078573 DOI: 10.3748/wjg.v21.i22.6952] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
13 Zhang Z, Ma K, Yang Z, Cheng Q, Hu X, Liu M, Liu Y, Liu T, Zhang M, Luo X, Chen T, Ning Q. Development and Validation of a Clinical Predictive Model for Bacterial Infection in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Infect Dis Ther 2021;10:1347-61. [PMID: 33991329 DOI: 10.1007/s40121-021-00454-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang B, Lv Z, Li H, Guo S, Liu D, Guo Y. Dietary l-arginine inhibits intestinal Clostridium perfringens colonisation and attenuates intestinal mucosal injury in broiler chickens. Br J Nutr 2017;118:321-32. [PMID: 28901890 DOI: 10.1017/S0007114517002094] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 5.2] [Reference Citation Analysis]
15 Kovacs G, Sipeki N, Suga B, Tornai T, Fechner K, Norman GL, Shums Z, Antal-Szalmas P, Papp M. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients. PLoS One 2018;13:e0194166. [PMID: 29590158 DOI: 10.1371/journal.pone.0194166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Sandin C, Eriksson P, Segelmark M, Skogh T, Kastbom A. IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis. Clin Exp Immunol 2016;184:208-15. [PMID: 26762653 DOI: 10.1111/cei.12769] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
17 Koutsounas I, Kaltsa G, Siakavellas SI, Bamias G. Markers of bacterial translocation in end-stage liver disease. World J Hepatol 2015; 7(20): 2264-2273 [PMID: 26380651 DOI: 10.4254/wjh.v7.i20.2264] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
18 Ma L, Liu X, Wu Q, Hu X, Liu H, Zhang J, Lee SS. Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy. J Cardiovasc Transl Res 2021. [PMID: 34417673 DOI: 10.1007/s12265-021-10161-5] [Reference Citation Analysis]
19 Huang C, Shao J, Lou C, Wu F, Ge T, Gao H, Zheng X, Dong X, Xu L, Chen Z. Reduced Energy Metabolism Impairs T Cell-Dependent B Cell Responses in Patients With Advanced HBV-Related Cirrhosis. Front Immunol 2021;12:660312. [PMID: 34248941 DOI: 10.3389/fimmu.2021.660312] [Reference Citation Analysis]
20 Xu R, Huang H, Zhang Z, Wang FS. The role of neutrophils in the development of liver diseases. Cell Mol Immunol. 2014;11:224-231. [PMID: 24633014 DOI: 10.1038/cmi.204.2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Nakamura H, Hanafusa N, Kitamura K, Nakamura H, Sekihara H, Shimizu K, Anayama M, Makino Y, Tamura K, Nagasawa M. Biochemical evaluation of processed ascites in patients undergoing cell-free and concentrated ascites reinfusion therapy. Ther Apher Dial 2020;24:516-23. [PMID: 32524759 DOI: 10.1111/1744-9987.13541] [Reference Citation Analysis]
22 Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol. 2017;30:486-497. [PMID: 28845103 DOI: 10.20524/aog.2017.0178] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
23 Li P, Gao M, Fu J, Yan S, Liu Y, Mahmood T, Lv Z, Guo Y. Dietary soya saponin improves the lipid metabolism and intestinal health of laying hens. Poultry Science 2021. [DOI: 10.1016/j.psj.2021.101663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN. Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. United European Gastroenterol J 2018;6:255-62. [PMID: 29511555 DOI: 10.1177/2050640617717156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
25 Zhang N, Sun J, Ji C, Bao X, Yuan C. Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram. Clin Rheumatol 2022. [PMID: 35918562 DOI: 10.1007/s10067-022-06314-9] [Reference Citation Analysis]
26 Kovács M, Müller KE, Papp M, Lakatos PL, Csöndes M, Veres G. New serological markers in pediatric patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(17): 4873-4882 [PMID: 24803798 DOI: 10.3748/wjg.v20.i17.4873] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
27 Xu R, Huang H, Zhang Z, Wang FS. The role of neutrophils in the development of liver diseases. Cell Mol Immunol. 2014;11:224-231. [PMID: 24633014 DOI: 10.1038/cmi.2014.2] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 16.5] [Reference Citation Analysis]
28 Lin S, Sun Q, Mao W, Chen Y. Serum Immunoglobulin A (IgA) Level Is a Potential Biomarker Indicating Cirrhosis during Chronic Hepatitis B Infection. Gastroenterol Res Pract 2016;2016:2495073. [PMID: 27123003 DOI: 10.1155/2016/2495073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
29 Li P, Gao M, Song B, Liu Y, Yan S, Lei J, Zhao Y, Li G, Mahmood T, Lv Z, Hu Y, Guo Y. Fecal Microbiota Transplantation Reshapes the Physiological Function of the Intestine in Antibiotic-Treated Specific Pathogen-Free Birds. Front Immunol 2022;13:884615. [DOI: 10.3389/fimmu.2022.884615] [Reference Citation Analysis]